Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Novolog (Pharm-Up 1966) Income Statement

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,038	2,022	1,643	1,508	1,255	1,134
Revenue Growth (YoY)	16.55%	23.01%	8.99%	20.13%	10.73%	12.90%
Cost of Revenue	1,864	1,837	1,470	1,328	1,101	1,003
Gross Profit	174.27	184.95	173.76	179.7	154.67	130.97
Selling, General & Admin	118.12	115.04	123.29	101.59	83.71	63.92
Other Operating Expenses	-13.93	-2.79	-3.49	0.31	1.55	0.2
Operating Expenses	104.19	112.25	119.8	101.89	85.26	73.44
Operating Income	70.08	72.7	53.97	77.81	69.41	57.54
Interest Expense	-12.45	-12.61	-12.87	-12.54	-8.47	-7.39
Interest & Investment Income	7.44	12.9	12.02	5.54	2.5	0.8
Earnings From Equity Investments	0.18	-0.44	-30.64	-4.61	-1.64	-
Currency Exchange Gain (Loss)	-0.72	-0.72	-0.07	1.36	-0.97	-0.98
Other Non Operating Income (Expenses)	-3.79	-3.79	-	-	-1.22	-1
EBT Excluding Unusual Items	60.75	68.04	22.4	67.55	59.6	48.97
Impairment of Goodwill	-14.78	-7.58	-50.67	-	-	-
Gain (Loss) on Sale of Investments	-	-	-0.5	-	-	-
Gain (Loss) on Sale of Assets	0.17	0.17	-0.14	0.34	0.53	3.56
Asset Writedown	-2.95	-2.95	-	-	-	-
Other Unusual Items	-14	-	-	-	-	-
Pretax Income	29.19	57.68	-28.91	67.89	60.13	52.52
Income Tax Expense	8.78	16.69	10.47	16.98	15.31	11.96
Earnings From Continuing Operations	20.41	41	-39.39	50.91	44.83	40.56
Minority Interest in Earnings	-0.34	-1.46	-2.62	-3.4	-2.51	-0.49
Net Income	20.07	39.54	-42	47.51	42.32	40.07
Net Income to Common	20.07	39.54	-42	47.51	42.32	40.07
Net Income Growth	-	-	-	12.27%	5.62%	295.25%
Shares Outstanding (Basic)	511	511	510	507	505	464
Shares Outstanding (Diluted)	511	511	511	516	515	472
Shares Change (YoY)	0.01%	-0.04%	-0.94%	0.14%	9.08%	22.05%
EPS (Basic)	0.04	0.08	-0.08	0.09	0.08	0.09
EPS (Diluted)	0.04	0.08	-0.08	0.09	0.08	0.09
EPS Growth	-	-	-	12.20%	-3.53%	226.92%
Free Cash Flow	88.25	145.12	163.77	87.68	52.75	32.87
Free Cash Flow Per Share	0.17	0.28	0.32	0.17	0.10	0.07
Dividend Per Share	0.039	0.049	0.029	0.066	0.094	0.026
Dividend Growth	-33.38%	66.49%	-55.20%	-30.00%	262.10%	-39.79%
Gross Margin	8.55%	9.15%	10.57%	11.92%	12.32%	11.55%
Operating Margin	3.44%	3.60%	3.28%	5.16%	5.53%	5.08%
Profit Margin	0.98%	1.96%	-2.56%	3.15%	3.37%	3.53%
Free Cash Flow Margin	4.33%	7.18%	9.96%	5.81%	4.20%	2.90%
EBITDA	114	106.65	134.71	102.12	91.66	80.13
EBITDA Margin	5.59%	5.27%	8.20%	6.77%	7.30%	7.07%
D&A For EBITDA	43.92	33.94	80.74	24.32	22.25	22.59
EBIT	70.08	72.7	53.97	77.81	69.41	57.54
EBIT Margin	3.44%	3.60%	3.28%	5.16%	5.53%	5.08%
Effective Tax Rate	30.07%	28.93%	-	25.01%	25.45%	22.77%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.